Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19589485rdf:typepubmed:Citationlld:pubmed
pubmed-article:19589485lifeskim:mentionsumls-concept:C0009450lld:lifeskim
pubmed-article:19589485lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:19589485lifeskim:mentionsumls-concept:C0009566lld:lifeskim
pubmed-article:19589485lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:19589485lifeskim:mentionsumls-concept:C1550587lld:lifeskim
pubmed-article:19589485lifeskim:mentionsumls-concept:C0966897lld:lifeskim
pubmed-article:19589485lifeskim:mentionsumls-concept:C2826293lld:lifeskim
pubmed-article:19589485lifeskim:mentionsumls-concept:C1705576lld:lifeskim
pubmed-article:19589485pubmed:issue8lld:pubmed
pubmed-article:19589485pubmed:dateCreated2009-7-10lld:pubmed
pubmed-article:19589485pubmed:abstractTextThe association of iron overload with complications of allogeneic hematopoietic stem cell transplantation (HSCT) has been suggested in previous studies. Because hepcidin plays a central role in the regulation of iron homeostasis, we analyzed the association between pretransplant serum hepcidin-25 levels and early infectious complications after allogeneic HSCT. We studied 55 consecutive adult patients with a median age of 47 years (range: 20-64 years) who underwent allogeneic HSCT for hematologic malignancies at our institution. Thirty-two patients had myelogenous malignancies; the remaining 23 had lymphogenous malignancies. The median pretransplant serum hepcidin level of patients in the study was 21.6 ng/mL (range: 1.4-371 ng/mL), which was comparable to that of healthy volunteers (median: 19.1 ng/mL [range: 2.3-37 ng/mL]; n = 17). When cumulative incidences of documented bacterial and cytomegalovirus (CMV) infections at day 100 were compared according to pretransplant hepcidin-25 levels, the incidence of bacterial, but not CMV, infection, was significantly higher in the high-hepcidin group (> or = 50 ng/mL; n = 17) than in the low-hepcidin group (<50 ng/mL; n = 38) (65% [95% confidence interval, 38%-82%] versus 11% [3%-23%]; P < .001). This finding was confirmed by multivariate Cox analysis adjusted for confounders, including pretransplant ferritin and C-reactive protein (CRP) levels. No fungal infection was documented in either group. These results suggest that the pretransplant serum hepcidin-25 level may be a useful marker for predicting the risk of early bacterial complications after allogeneic HSCT. Larger prospective studies are, however, warranted to confirm our findings.lld:pubmed
pubmed-article:19589485pubmed:languageenglld:pubmed
pubmed-article:19589485pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19589485pubmed:citationSubsetIMlld:pubmed
pubmed-article:19589485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19589485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19589485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19589485pubmed:statusMEDLINElld:pubmed
pubmed-article:19589485pubmed:monthAuglld:pubmed
pubmed-article:19589485pubmed:issn1523-6536lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:MatsuoKeitaro...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:UchiyamaTakas...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:KawabataHiros...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:KondoTadakazu...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:IchinoheTatsu...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:IshikawaTakay...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:YamashitaKouh...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:TomosugiNaohi...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:MizumotoChisa...lld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:KandaJunyaJlld:pubmed
pubmed-article:19589485pubmed:authorpubmed-author:TsuchidaHidey...lld:pubmed
pubmed-article:19589485pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19589485pubmed:volume15lld:pubmed
pubmed-article:19589485pubmed:ownerNLMlld:pubmed
pubmed-article:19589485pubmed:authorsCompleteYlld:pubmed
pubmed-article:19589485pubmed:pagination956-62lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:meshHeadingpubmed-meshheading:19589485...lld:pubmed
pubmed-article:19589485pubmed:year2009lld:pubmed
pubmed-article:19589485pubmed:articleTitleClinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation.lld:pubmed
pubmed-article:19589485pubmed:affiliationDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. jkanda16@kuhp.kyoto-u.ac.jplld:pubmed
pubmed-article:19589485pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19589485pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19589485lld:pubmed